Cannabinoid CB2 receptors are expressed in glutamate neurons in the red nucleus and functionally modulate motor behavior in mice
Hai-Ying Zhang,Hui Shen,Ming Gao,Zegang Ma,Briana J Hempel,Guo-Hua Bi,Eliot L Gardner,Jie Wu,Zheng-Xiong Xi,Briana J. Hempel,Eliot L. Gardner
DOI: https://doi.org/10.1016/j.neuropharm.2021.108538
IF: 5.273
2021-05-01
Neuropharmacology
Abstract:<p><em>Cannabinoids produce a number of central nervous sys</em>tem effects via the CB<sub>2</sub> receptor (CB<sub>2</sub>R), including analgesia, antianxiety, anti-reward, hypoactivity and attenuation of opioid-induced respiratory depression. However, the cellular distributions of the CB<sub>2</sub>Rs in the brain remain unclear. We have reported that CB<sub>2</sub>Rs are expressed in midbrain dopamine (DA) neurons and functionally regulate DA-mediated behavior(s). Unexpectedly, high densities of CB<sub>2</sub>-like signaling were also found in a neighboring motor structure – the red nucleus (RN) of the midbrain. In the present study, we systematically explored CB<sub>2</sub>R expression and function in the RN. Immunohistochemistry and <em>in situ</em> hybridization assays showed high densities of CB<sub>2</sub>R-immunostaining and mRNA signal in RN magnocellular glutamate neurons in wildtype and CB<sub>1</sub>-knockout, but not CB<sub>2</sub>-knockout, mice. <em>Ex vivo</em> electrophysiological recordings in midbrain slices demonstrated that CB<sub>2</sub>R activation by JWH133 dose-dependently inhibited firing rates of RN magnocellular neurons in wildtype, but not CB<sub>2</sub>-knockout, mice, while having no effect on RN GABA neurons in transgenic GAD67-GFP reporter mice, suggesting CB<sub>2</sub>-mediated effects on glutamatergic neurons. In addition, microinjection of JWH133 into the RN produced robust ipsilateral rotations in wildtype, but not CB<sub>2</sub>-knockout mice, which was blocked by pretreatment with either a CB<sub>2</sub> or DA D1 or D2 receptor antagonist, suggesting a DA-dependent effect. Finally, fluorescent tract tracing revealed glutamatergic projections from the RN to multiple brain areas including the ventral tegmental area, nucleus accumbens, thalamus, and cerebellum. These findings suggest that CB<sub>2</sub>Rs in RN glutamate neurons functionally modulate motor activity, and therefore, constitute a new target in cannabis-based medication development for motor disorders.</p>
pharmacology & pharmacy,neurosciences